Klaus Vedfelt This is my first look at Chimerix (NASDAQ:CMRX) which drew my attention after its recent 11/2022 Q3, 2022 earnings call (the”Call“). Chimerix’s TEMBEXA deal has been virtuosic. TEMBEXA (Brincidofovir, CMX001) has had an […]
Dave Zhong Elevator Pitch I have a Hold rating for LexinFintech Holdings Ltd.’s (NASDAQ:LX) stock, which remains unchanged from my prior article for LX published on August 30, 2022. I lowered my investment rating for […]
sankai One thing I can tell you for certain about last week’s big rally on Thursday and Friday. There were a lot of people who desperately wanted a good excuse to buy stocks. And buy […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.